USE OF SYNTHETIC SINGLE-STRANDED RNA (SSRNA) AS A THERAPEUTIC AGENT TO ACTIVATE NOD2-DEPENDENT IMMUNE RESPONSE AGAINST VIRAL INFECTION

摘要

Disclosed are methods, compositions, and kits for modifying an innate immune response in a subject, such as an innate immune response to a viral infection, employing single stranded RNA that can bind to a NOD2 polypeptide.